Clorox CLX NYSE · Consumer defensive · United States
$108.40 +1.59% +$1.70
Summary
62 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 59% a year over the last 3 years.
- It earns 23 USD a year on every 100 USD of invested capital.
- It has raised its dividend 25 years in a row.
- The share price is below the Bulios Fair Price.
What to watch
- Repaying its net debt would take 4.1 years of operating profit.
- Revenue fell by 3.1% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.1 USD for 1 USD of yearly profit. Over the last five years it was 53.9 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 1.8% a year over 5 years. Over the last 3 years it fell by 3.1% a year. For the next fiscal year analysts expect revenue to grow by 14%. Earnings per share grew by 59% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 58 USD
- Research and development 1.6 USD
- Sales and administration 15 USD
- Taxes and other 16 USD
- Net profit 9.4 USD
Net profit, industry median (Household & Personal Products) 9.4 USD
Out of every 100 USD of revenue, 9.4 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 12.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 4.67%
- Paid out of profit
- 89%
- Raised in a row
- 25 years
You receive $4.98 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 21
- Sell 5
Today's price within the analysts' price targets
The average target of $91.67 is 15% below today's price. 10% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Health and Wellness 40%
- Household 27%
- Lifestyle 17%
- International 17%
By region
- UNITED STATES 84%
- Foreign 16%
Health and Wellness brings in 40% of revenue.
Segments in detail